Page last updated: 2024-11-02

pioglitazone and Abnormalities, Autosome

pioglitazone has been researched along with Abnormalities, Autosome in 3 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Research Excerpts

ExcerptRelevanceReference
"Pioglitazone is a prototype of thiazolidinediones, used for the treatment of type 2 diabetes mellitus."1.38Evaluation of vitamin B12 effects on DNA damage induced by pioglitazone. ( Al-Azzam, S; Alzoubi, K; Hussain, N; Khabour, O; Mhaidat, N, 2012)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Oz Gul, O1
Cinkilic, N1
Gul, CB1
Cander, S1
Vatan, O1
Ersoy, C1
Yılmaz, D1
Tuncel, E1
Yokote, K1
Saito, Y1
Alzoubi, K1
Khabour, O1
Hussain, N1
Al-Azzam, S1
Mhaidat, N1

Other Studies

3 other studies available for pioglitazone and Abnormalities, Autosome

ArticleYear
Comparative genotoxic and cytotoxic effects of the oral antidiabetic drugs sitagliptin, rosiglitazone, and pioglitazone in patients with type-2 diabetes: a cross-sectional, observational pilot study.
    Mutation research, 2013, Sep-18, Volume: 757, Issue:1

    Topics: Aged; Blood Glucose; Chromosome Aberrations; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Fem

2013
Extension of the life span in patients with Werner syndrome.
    Journal of the American Geriatrics Society, 2008, Volume: 56, Issue:9

    Topics: Adult; Chromosome Aberrations; Disease Progression; Genes, Recessive; Humans; Hydroxymethylglutaryl-

2008
Evaluation of vitamin B12 effects on DNA damage induced by pioglitazone.
    Mutation research, 2012, Oct-09, Volume: 748, Issue:1-2

    Topics: Adult; Antimutagenic Agents; Chromosome Aberrations; DNA Damage; Humans; Hypoglycemic Agents; Male;

2012